Investing Profile

Liam Ratcliffe

InvestorVCAngel

Head of Biotechnology at Access Biotechnology

Your Intro Paths to Liam Ratcliffe

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Liam Ratcliffe on

Current Investing Position

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Liam Ratcliffe is on these Sector & Stage Rankings

Liam Ratcliffe's Investments On Record (12)

Company	StageDateRound Size	Total Raised
Eliem Therapeutics	Series BMay 2021$60M Series AMar 2021$80M	$260M
Co-investors: Ohad Hammer (Pontifax Venture Capital), Andrew Levin (RA Capital)
Shoopy	SeedFeb 2021$250K	$250K
Passage Bio	Series BSep 2019$110M Series AFeb 2019$120M	$230M
Co-investors: Carl Gordon (OrbiMed), Patrick Heron (Frazier Healthcare Partners)
CuraSen Therapeutics	Series AOct 2018$55M	$55M
Arvinas	Series CApr 2018$55M Series BOct 2015$42M	$140M
Co-investors: Kush Parmar (5am Ventures), Stephen Squinto (OrbiMed), Tim Shannon (Canaan Partners), Colleen Cuffaro (Canaan Partners), Martin Alexander Gershon (Endeavor Venture Funds), Daniel Wagner (Connecticut Innovations), Andrew Levin (RA Capital), Jakob Loven (Nextech Invest)
Aptinyx	Series BDec 2017$70M Series AMay 2016$65M	$140M
Co-investors: Adam Koppel (Bain Capital Life Sciences)
Neuronetics	Series GJun 2017$15M Series FApr 2015$34M Series EMay 2011$30M Series DOct 2009$30M	$170M
Co-investors: Kevin Bitterman (Atlas Venture), Leslie Bottorff (GE Ventures), Bruce Cleveland (Wildcat Ventures), Gil Kliman (InterWest)
Deciphera Pharmaceuticals	Series BSep 2015$75M	$75M